Clinical Trial Update: Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated Peptides [Phase 1, Phase 2]

View source ↗

Summary

This document provides a clinical trial update for a Phase 1/Phase 2 adjuvant antigen-specific immunotherapy using tumor-associated peptides in patients with ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Renal Cell Cancer, Advanced Renal Cell Cancer | Phase 1, Phase 2 | Status: UNKNOWN